<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Yestino - The Signal · Merck</title><link>https://yestino.com/entities/merck-63a7d4</link><description>Every event involving Merck</description><language>en</language><atom:link href="https://yestino.com/entities/merck-63a7d4/feed.xml" rel="self" type="application/rss+xml"/><item><title>Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%</title><link>https://yestino.com/events/moderna-and-merck-say-their-mrna-cancer-vaccine-cut-death-re-85801f</link><guid isPermaLink="true">https://yestino.com/events/moderna-and-merck-say-their-mrna-cancer-vaccine-cut-death-re-85801f</guid><pubDate>Thu, 22 Oct 2026 22:12:19 GMT</pubDate><description>Markers released top-line results today after previously reporting the trial succeeded.
Sources: Ars Technica</description></item><item><title>Moderna and Merck shares soar on mRNA cancer vaccine</title><link>https://yestino.com/events/moderna-and-merck-shares-soar-on-mrna-cancer-vaccine-11e1b2</link><guid isPermaLink="true">https://yestino.com/events/moderna-and-merck-shares-soar-on-mrna-cancer-vaccine-11e1b2</guid><pubDate>Wed, 19 Aug 2026 20:04:57 GMT</pubDate><description>Moderna and Merck shares soared on Wednesday after the companies said a personalized mRNA treatment hit its target of preventing skin cancer from recurring or…
Sources: Axios</description></item></channel></rss>